|
|
S |
Safety |
|
T |
Tolerability |
|
E |
Effectiveness |
|
P |
Price |
|
S |
Simplicity |
The STEPS approach is used after a review of:
|
 |
Clinical Literature |
|
 |
Expert Opinions |
|
 |
Clinical Practice Guidelines |
The review includes relevant findings of government
agencies, medical associations,
national
commissions, peer-reviewed journals, and other
relevant sources.
Cost is considered a factor in formulary decisions
only when little or no difference exist in
comparative efficacy and other drug-specific
parameters. Manufacturer arrangement and volume
discounts are considered only in respect to their
effect on net drug cost. |